CA
CTKB icon

Cliff Asness’s Cytek Biosciences CTKB Stock Holding History

Cliff Asness’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.61M Sell
813,971
-98,371
-11% -$420K ﹤0.01% 2214
2026
Q1 		$3.99M Buy
912,342
+168,887
+23% +$797K ﹤0.01% 1893
2025
Q4 		$3.75M Sell
743,455
-276,435
-27% -$1.28M ﹤0.01% 1751
2025
Q3 		$3.54M Sell
1,019,890
-218,503
-18% -$820K ﹤0.01% 1656
2025
Q2 		$4.21M Buy
1,238,393
+585,116
+90% +$1.95M ﹤0.01% 1381
2025
Q1 		$2.62M Buy
653,277
+521,135
+394% +$2.7M ﹤0.01% 1467
2024
Q4 		$858K Buy
132,142
+52,236
+65% +$311K ﹤0.01% 1969
2024
Q3 		$443K Buy
79,906
+19,759
+33% +$112K ﹤0.01% 2229
2024
Q2 		$336K Buy
60,147
+40,240
+202% +$242K ﹤0.01% 2220
2024
Q1 		$134K Sell
19,907
-36,299
-65% -$287K ﹤0.01% 2310
2023
Q4 		$513K Buy
56,206
+17,167
+44% +$108K ﹤0.01% 1874
2023
Q3 		$215K Buy
39,039
+13,057
+50% +$105K ﹤0.01% 2119
2023
Q2 		$222K Buy
+25,982
New +$233K ﹤0.01% 2057
2022
Q4 		– Sell
-31,163
Closed -$459K – 2214
2022
Q3 		$459K Buy
+31,163
New +$405K ﹤0.01% 1821

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cliff Asness's CTKB Position: Q2 2026 in Review

Cliff Asness reduced its Cytek Biosciences (CTKB) stake by 11% in Q2 2026, selling an estimated $420K and leaving 813,971 shares worth $3.61M. The position accounts for ﹤0.01% of the portfolio, ranked #2214.

Cliff Asness first reported a position in CTKB in Q3 2022 and has held it in 14 quarters since. The position peaked at $4.21M in Q2 2025. 154 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Cliff Asness held 813,971 shares of Cytek Biosciences worth $3.61M as of Q2 2026.
  • Cliff Asness sold 98,371 Cytek Biosciences shares in Q2 2026, an estimated $420K.
  • Cytek Biosciences made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2214 holding.
  • Cliff Asness first reported a position in Cytek Biosciences in Q3 2022 and has held it in 14 quarters since.
  • Cliff Asness's Cytek Biosciences position peaked at $4.21M in Q2 2025.
  • 154 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.